α-MSH (alpha-melanocyte-stimulating hormone): the body's broad-spectrum melanocortin signal

One short peptide the body has always used to protect, colour, and calm — the system's oldest sentence, spoken wherever a receptor is listening.

α-MSH — alpha-melanocyte-stimulating hormone — is the molecule the entire melanocortin system is named after. It is small, just thirteen amino acids, yet it is the natural key that fits four of the five receptors, and it turns up wherever the body needs to set pigment, appetite, energy balance, or inflammation. If the receptors are the switches of this system, α-MSH is the prototypical finger that flips them.^[5]

One cut from a bigger protein

α-MSH does not exist as its own gene. It is carved out of a much larger precursor, proopiomelanocortin (POMC), by processing enzymes that snip the parent protein into a family of smaller peptides — α-MSH, the other MSH forms, and ACTH among them.^[1] Because the same precursor yields several products, which peptide dominates depends on the tissue: skin melanocytes and the pituitary make α-MSH for pigment and hormonal signalling, while POMC neurons in the hypothalamic arcuate nucleus and the brainstem release it to control feeding.^[3]

That shared origin explains a common point of confusion. α-MSH’s active core sequence is contained within ACTH — they are overlapping cuts of the same protein — which is why the two behave like cousins rather than strangers. The difference that matters is selectivity, and it comes up again and again on this site: α-MSH ignores MC2R, the adrenal receptor that responds to ACTH alone.

Four receptors, four jobs

The remarkable thing about α-MSH is that a single molecule produces completely different outcomes depending on which receptor reads it — the same signal, four different meanings.^[2]

• MC1R — pigment. In the skin, α-MSH drives melanocytes to switch from red-yellow pheomelanin to dark, UV-shielding eumelanin. This is the receptor behind tanning, hair colour, and much of skin-cancer risk.^[2]
• MC4R — satiety. In the hypothalamus, α-MSH released by POMC neurons activates MC4R to produce the sensation of fullness and to raise energy expenditure. This is the circuit that setmelanotide was built to repair.^[3]
• MC3R — energy balance. The quieter appetite receptor, where α-MSH helps tune how the body partitions and defends its energy stores rather than switching hunger on and off outright.^[3]
• Immune tissue — anti-inflammation. Beyond pigment and appetite, α-MSH is a potent endogenous anti-inflammatory signal, tempering immune responses — a role that has made the melanocortin pathway a drug target well outside metabolism.^[4]

(The fifth receptor, MC5R, governs exocrine glands and is also activated by α-MSH, though its physiology is the least mapped of the set.) To see the full activity grid at a glance — what binds which receptor and how — use the receptor–ligand explorer.

The off switches

A signal is only useful if it can be turned off, and α-MSH has two kinds of brake. The first is built into the molecule: natural α-MSH is short-lived, broken down by enzymes within minutes of release, so its effect is inherently self-limiting.^[1]The second is active opposition. At MC3R and MC4R, the hunger peptideAgRP works against α-MSH as an antagonist and inverse agonist, creating a push–pull that sets appetite tone. In the skin, theagouti protein (ASIP) blocks α-MSH at MC1R, flipping pigment production back toward pheomelanin — the same mechanism that patterns animal coats.

Why every melanocortin drug is an α-MSH impersonator

Because α-MSH is so central and so quickly degraded, the obvious way to make a melanocortin medicine is to build a sturdier copy of it. That is exactly what the drug catalogue turns out to be:

• Afamelanotide is a superpotent, longer-lasting α-MSH analogue used to drive MC1R pigmentation as protection in erythropoietic protoporphyria.
• Melanotan II is a non-selective α-MSH mimic sold on the grey market for tanning — the same MC1R pigment effect, without the safety guardrails.
• Setmelanotide is an α-MSH-like agonist tuned toward MC4R, re-supplying the satiety signal in diseases where the natural one is missing.
• Bremelanotide (PT-141) is another α-MSH-derived agonist whose central MC4R activity underlies its use for sexual desire.

Seen this way, the whole therapeutics pillar is a set of variations on one theme: take the natural broad-spectrum signal, make it last, and — where possible — point it at a single receptor. The trade-offs that follow, from skin darkening to nausea, come straight from α-MSH’s own biology. For why those effects are inseparable from the mechanism, see why melanocortin agonists make you queasy and tan.

The honest bottom line

α-MSH is the clearest single illustration of how the melanocortin system works: one small peptide, cut from a shared precursor, read four different ways by four different receptors. It is the reason a tanning peptide can affect appetite and a weight drug can darken skin — the outputs look unrelated only until you notice they all trace back to the same molecule. Understand α-MSH and the rest of this site, from receptors to drugs, stops being a list of separate facts and becomes one connected picture.

Common questions

What is α-MSH?+

Alpha-melanocyte-stimulating hormone (α-MSH) is a short 13-amino-acid peptide cut from the larger precursor protein POMC. It is the prototypical melanocortin — the body’s natural agonist for four of the five melanocortin receptors — and it drives skin pigmentation, satiety, energy balance, and anti-inflammatory signalling depending on where it is released.

What does α-MSH do?+

The same molecule does different jobs in different tissues. In the skin it activates MC1R to make the dark pigment eumelanin. In the hypothalamus it activates MC4R to signal fullness and MC3R to tune energy partitioning. Across immune tissue it dampens inflammation. It is one signal read by several receptors, not several hormones.

Is α-MSH the same as ACTH?+

They are cousins from the same parent protein. Both α-MSH and ACTH are carved out of POMC, and α-MSH’s core sequence is actually contained within ACTH. The key difference: ACTH is the only natural activator of MC2R (the adrenal cortisol receptor), while α-MSH does not act on MC2R at all.

Why do melanocortin drugs copy α-MSH?+

Natural α-MSH is powerful but short-lived — enzymes break it down within minutes. Drugs such as afamelanotide, melanotan II, setmelanotide, and bremelanotide are engineered analogues: they keep α-MSH’s receptor-activating core but resist degradation and, in some cases, favour one receptor over the others. Each is essentially a more durable, more targeted impersonation of the natural peptide.

What opposes α-MSH?+

At the appetite receptors MC3R and MC4R, α-MSH is countered by AgRP, the "hunger peptide," which acts as an antagonist and inverse agonist. In the skin, the agouti protein (ASIP) blocks α-MSH at MC1R, switching pigment production from dark eumelanin toward red-yellow pheomelanin. Melanocortin tone is always this push–pull between an activator and its brake.

References

1. 1.Journal of Molecular Medicine. α-Melanocyte-stimulating hormone: production and degradation. Review of α-MSH synthesis from POMC and its rapid enzymatic turnover. 2010. link ↗
2. 2.Open-access review (PMC). Alpha-melanocyte stimulating hormone (α-MSH): biology, clinical relevance and implication in melanoma. Comprehensive review of α-MSH biology, receptor targets, and pigment signalling. 2023. link ↗
3. 3.Neuroendocrinology (Karger). Alpha-Melanocyte-Stimulating Hormone–Mediated Appetite Regulation in the Central Nervous System. Review of the arcuate POMC → α-MSH → MC4R satiety pathway. 2023. link ↗
4. 4.Peptides (via PubMed). α-Melanocyte stimulating hormone, inflammation and human melanoma. On the anti-inflammatory activity of α-MSH. 2005. link ↗
5. 5.ScienceDirect Topics. Alpha-Melanocyte-Stimulating Hormone — an overview. Aggregated reference on α-MSH structure, sources, and receptor activity. 2024. link ↗